Update on HER-2 as a target for cancer therapy: Intracellular signaling pathways of ErbB2/HER-2 and family members
ErbB (also termed HER) receptors are expressed in various tissues of epithelial, mesenchymal and neuronal origin, in which they are involved in the control of diverse biological processes such as proliferation, differentiation, migration and apoptosis. Furthermore, their deregulated expression has b...
שמור ב:
| הוצא לאור ב: | Breast Cancer Res |
|---|---|
| מחבר ראשי: | |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMC
2001
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC138705/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11737890/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/bcr327 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|